CE-certified software provides diabetes treatment recommendations in seconds

Premiere on World Diabetes Day, 14 November 2025: CE-certified software delivers treatment recommendations for diabetes in seconds

New CE-certified software from SINOVO health solutions GmbH provides medically sound, guideline-based therapy recommendations for diabetes treatment in seconds for the first time. This is a premiere from SINOVO on World Diabetes Day on 14 November 2025.

Software provides an overview in seconds – new CE-certified solution for diabetes therapy

In modern diabetology, every minute counts. In view of complex clinical pictures and rising patient numbers, SINOVO health solutions GmbH has developed the medical software AUdiTE, which supports doctors in the rapid and precise analysis of patient data. AUdiTE stands for automated support for diabetic diagnoses and therapy decisions: https://www.sidiary.de/audite

The new CE-certified solution for diabetes therapy provides an overview of individualised therapy recommendations within seconds – making it the first of its kind on the European market.

Test AUdiTE free of charge for 60 days

The AUdiTE software is available as a desktop solution within the SiDiary Professional diabetes management software for healthcare professionals. Interested medical professionals can test the software free of charge for 60 days starting on 14 November 2025. To do so, simply send an informal request to info@sinovo.de.

Software-based decision support for medical practice

This is how software-supported decision support works in practice: the software analyses structured patient data, automatically recognises therapy-relevant patterns and evaluates them using over 100 medical rules. This allows the identification of unsuitable basal insulin doses, incorrect carbohydrate ratios or psychological factors such as fear of hypoglycaemia.

The recommendations are transparently justified and can be directly integrated into therapy optimisation.

‘AUdiTE brings order to the flood of data in diabetology and gives doctors what they need most: more time for their patients,’ says Alf Windhorst, Managing Director of SINOVO health solutions GmbH.

Medical quality through CE certification

The software bears the CE mark as a medical device and thus meets all regulatory requirements for clinical use. CE certification guarantees medical quality.

Unlike existing diabetes tools, which are primarily used for data management, the SINOVO solution offers genuine medical decision support.

The underlying recommendations are based on current guidelines and are continuously supplemented by new scientific findings.

Practical support when time is of the essence

During diabetes consultations, doctors have an average of only seven minutes to analyse, advise and adjust treatment.

AUdiTE offers noticeable relief and practical support when time is of the essence: within seconds, relevant abnormalities, risks and opportunities for improvement are identified – including specific options for action.

This enables more informed, comprehensible decision-making and at the same time increases treatment safety.

Learning technology – integrated into existing systems

The SINOVO software has a modular structure and can be seamlessly integrated into existing diabetes management systems – whether as an online application, mobile app or desktop solution.

It also features learning mechanisms that adapt to feedback from medical professionals, thereby continuously improving the quality of recommendations.

Conclusion

In conclusion, it can be said that SINOVO has set a milestone in digital diabetology with its new CE-certified software.

For the first time, doctors have access to a system that provides medically verified recommendations within seconds, is clinically approved and can be integrated into everyday practice.
This not only makes diabetes therapy more efficient, but also safer – benefiting both healthcare professionals and patients alike.

Press contact

SINOVO health solutions GmbH, Jan Filip, Willy-Brandt-Str. 4, 61118 Bad Vilbel, Tel.: +49 6101 590 90 00, E-Mail: presse@sinovo.de , Web: sinovo.en